Cepheid Pipeline Update Focuses on Tests for CT/NG, Cancer, TB
June 07, 2012
Cepheid Pipeline Update Focuses on Tests for CT/NG, Cancer, TB
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Cepheid Xpert CT/NG Gets CLIA 'Moderate Complexity' Rating
January 15, 2013 / GenomeWeb Daily News - Cepheid Discloses Further Terms of HIV Test Pact with FIND
February 3, 2011 / GenomeWeb Daily News - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider - Dx Focus: Cepheid Xpert CT/NG; AITbiotech abTES Flu 4-Plex and MTB Real-Time Assays
January 3, 2013 / PCR Insider